XML 33 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)
$ in Millions
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Series C Preferred stock
Series D Preferred stock
Total
Beginning balance (shares) at Dec. 31, 2017             15,671,730
Beginning balance at Dec. 31, 2017             $ 60.4
Convertible Preferred Stock              
Issuance of preferred stock, net of issuance costs         $ 119.8    
Issuance of preferred stock (shares)         8,700,224    
Exercise of Series A Preferred stock warrants             $ 0.6
Exercise of Series A Preferred stock warrants (in shares)             73,601
Ending balance (shares) at Dec. 31, 2018         8,700,224   24,445,555
Ending balance at Dec. 31, 2018         $ 119.8   $ 180.8
Beginning balance (shares) at Dec. 31, 2017 10,887,059            
Beginning balance at Dec. 31, 2017 $ 0.0 $ 8.5 $ (36.9) $ 0.0     (28.4)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Exercise of stock options (shares) 34,125            
Repayment of partial recourse loan   0.1         0.1
Repayment of partial recourse loan (shares) 62,500            
Stock-based compensation   2.1         2.1
Net loss     (52.9)       $ (52.9)
Ending balance (shares) at Dec. 31, 2018 10,983,684           10,983,684
Ending balance at Dec. 31, 2018 $ 0.0 10.7 (89.8) 0.0     $ (79.1)
Convertible Preferred Stock              
Issuance of preferred stock (shares)             3,622
Ending balance (shares) at Mar. 31, 2019             24,449,177
Ending balance at Mar. 31, 2019             $ 180.8
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Exercise of stock options (shares) 3,125            
Stock-based compensation   0.4         0.4
Net loss     (21.6)       (21.6)
Ending balance (shares) at Mar. 31, 2019 10,986,809            
Ending balance at Mar. 31, 2019   11.1 (111.4)       $ (100.3)
Beginning balance (shares) at Dec. 31, 2018         8,700,224   24,445,555
Beginning balance at Dec. 31, 2018         $ 119.8   $ 180.8
Ending balance (shares) at Sep. 30, 2019             31,557,107
Ending balance at Sep. 30, 2019             $ 480.2
Beginning balance (shares) at Dec. 31, 2018 10,983,684           10,983,684
Beginning balance at Dec. 31, 2018 $ 0.0 10.7 (89.8) 0.0     $ (79.1)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Net loss             (75.8)
Ending balance (shares) at Sep. 30, 2019 11,263,261            
Ending balance at Sep. 30, 2019   13.5 (165.6) (0.1)     $ (152.2)
Beginning balance (shares) at Dec. 31, 2018         8,700,224   24,445,555
Beginning balance at Dec. 31, 2018         $ 119.8   $ 180.8
Convertible Preferred Stock              
Issuance of preferred stock, net of issuance costs           $ 299.4  
Issuance of preferred stock (shares)         3,622 7,107,930  
Ending balance (shares) at Dec. 31, 2019         8,703,846 7,107,930 31,557,107
Ending balance at Dec. 31, 2019         $ 119.8 $ 299.4 $ 480.2
Beginning balance (shares) at Dec. 31, 2018 10,983,684           10,983,684
Beginning balance at Dec. 31, 2018 $ 0.0 10.7 (89.8) 0.0     $ (79.1)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Exercise of stock options (shares) 182,057           182,057
Exercise of stock options   0.5         $ 0.5
Repayment of partial recourse loan   0.2         0.2
Repayment of partial recourse loan (shares) 105,487            
Stock-based compensation   4.3         4.3
Net loss     (108.5)       (108.5)
Other comprehensive income       0.1     $ 0.1
Ending balance (shares) at Dec. 31, 2019 11,271,228           11,271,228
Ending balance at Dec. 31, 2019 $ 0.0 15.7 (198.3) 0.1     $ (182.5)
Beginning balance (shares) at Mar. 31, 2019             24,449,177
Beginning balance at Mar. 31, 2019             $ 180.8
Convertible Preferred Stock              
Issuance of preferred stock, net of issuance costs             $ 174.4
Issuance of preferred stock (shares)             4,146,294
Ending balance (shares) at Jun. 30, 2019             28,595,471
Ending balance at Jun. 30, 2019             $ 355.2
Beginning balance (shares) at Mar. 31, 2019 10,986,809            
Beginning balance at Mar. 31, 2019   11.1 (111.4)       (100.3)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Exercise of stock options (shares) 97,625            
Exercise of stock options   0.3         0.3
Stock-based compensation   0.4         0.4
Net loss     (23.1)       (23.1)
Ending balance (shares) at Jun. 30, 2019 11,084,434            
Ending balance at Jun. 30, 2019   11.8 (134.5)       (122.7)
Convertible Preferred Stock              
Issuance of preferred stock, net of issuance costs             $ 125.0
Issuance of preferred stock (shares)             2,961,636
Ending balance (shares) at Sep. 30, 2019             31,557,107
Ending balance at Sep. 30, 2019             $ 480.2
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Exercise of stock options (shares) 73,340            
Exercise of stock options   0.1         0.1
Repayment of partial recourse loan   0.1         0.1
Repayment of partial recourse loan (shares) 105,487            
Stock-based compensation   1.5         1.5
Net loss     (31.1)       (31.1)
Other comprehensive income       (0.1)     (0.1)
Ending balance (shares) at Sep. 30, 2019 11,263,261            
Ending balance at Sep. 30, 2019   13.5 (165.6) (0.1)     $ (152.2)
Beginning balance (shares) at Dec. 31, 2019         8,703,846 7,107,930 31,557,107
Beginning balance at Dec. 31, 2019         $ 119.8 $ 299.4 $ 480.2
Ending balance (shares) at Mar. 31, 2020             31,557,107
Ending balance at Mar. 31, 2020             $ 480.2
Beginning balance (shares) at Dec. 31, 2019 11,271,228           11,271,228
Beginning balance at Dec. 31, 2019 $ 0.0 15.7 (198.3) 0.1     $ (182.5)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Exercise of stock options (shares) 54,374            
Stock-based compensation   2.2         2.2
Net loss     (36.5)       (36.5)
Ending balance (shares) at Mar. 31, 2020 11,825,602            
Ending balance at Mar. 31, 2020   30.1 (234.8) 0.1     $ (204.6)
Beginning balance (shares) at Dec. 31, 2019         8,703,846 7,107,930 31,557,107
Beginning balance at Dec. 31, 2019         $ 119.8 $ 299.4 $ 480.2
Ending balance (shares) at Sep. 30, 2020             0
Ending balance at Sep. 30, 2020             $ 0.0
Beginning balance (shares) at Dec. 31, 2019 11,271,228           11,271,228
Beginning balance at Dec. 31, 2019 $ 0.0 15.7 (198.3) 0.1     $ (182.5)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Exercise of stock options (shares)             92,157
Net loss             $ (88.4)
Ending balance (shares) at Sep. 30, 2020 56,584,029           56,584,029
Ending balance at Sep. 30, 2020 $ 0.0 855.0 (286.7) 0.7     $ 569.0
Beginning balance (shares) at Mar. 31, 2020             31,557,107
Beginning balance at Mar. 31, 2020             $ 480.2
Ending balance (shares) at Jun. 30, 2020             31,557,107
Ending balance at Jun. 30, 2020             $ 480.2
Beginning balance (shares) at Mar. 31, 2020 11,825,602            
Beginning balance at Mar. 31, 2020   30.1 (234.8) 0.1     (204.6)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Exercise of stock options (shares) 30,562            
Exercise of stock options   0.1         0.1
Repayment of partial recourse loan   1.3         1.3
Repayment of partial recourse loan (shares) 513,537            
Stock-based compensation   2.4         2.4
Net loss     (21.0)       (21.0)
Other comprehensive income       0.2     0.2
Ending balance (shares) at Jun. 30, 2020 12,369,701            
Ending balance at Jun. 30, 2020 $ 0.0 33.9 (255.8) 0.3     $ (221.6)
Ending balance (shares) at Sep. 30, 2020             0
Ending balance at Sep. 30, 2020             $ 0.0
Increase (Decrease) in Stockholders' Deficit [Roll Forward]              
Issuance of common stock upon closing of initial public offering (shares) 12,650,000            
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriting fees of $28.9 million   338.0         338.0
Exercise of stock options (shares) 7,221            
Exercise of stock options   0.2         0.2
Stock-based compensation   2.7         2.7
Net loss     (30.9)       (30.9)
Other comprehensive income       0.4     $ 0.4
Ending balance (shares) at Sep. 30, 2020 56,584,029           56,584,029
Ending balance at Sep. 30, 2020 $ 0.0 $ 855.0 $ (286.7) $ 0.7     $ 569.0